ANGIEX
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 24 Oct 2023)
What this means for you
Registered since 04 Jul 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86948315
- Registration number
- 5237897
- Mark type
- Stylized text
- Filed
- 22 Mar 2016
- Published for opposition
- 06 Sept 2016
- Registered
- 04 Jul 2017
- Attorney of record
- Chelsea E. Carbone
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Development of pharmaceutical preparations, medicines, and diagnostics; Research in the field of drugs and diagnostic preparations for detecting, imaging and treating cancer; Conducting early evaluations in the field of new pharmaceuticals and diagnostics preparations
Owner
- Angiex, Inc., Cambridge, MA, US
- Angiex, Inc., Cambridge, MA, US
- Angiex, Inc., Cambridge, MA, US
Prosecution history
- 24 Oct 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 24 Oct 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 24 Oct 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 Apr 2023 — TEAS SECTION 8 & 15 RECEIVED
- 04 Jul 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Jul 2017 — REGISTERED-PRINCIPAL REGISTER
- 01 Jun 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 May 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 May 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 May 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 May 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 May 2017 — SOU TEAS EXTENSION RECEIVED
- 24 Apr 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Apr 2017 — NON-FINAL ACTION E-MAILED
- 24 Apr 2017 — SU - NON-FINAL ACTION - WRITTEN